Protalix BioTherapeutics (PLX) Inventory (2010 - 2026)

Protalix BioTherapeutics' Inventory history runs 17 years deep, the most recent figure standing at $30.5 million for Q1 2026.

• In Q1 2026, Inventory rose 56.23% year-over-year to $30.5 million; the TTM figure through Mar 2026 stood at $30.5 million (up 56.23% YoY), while the FY2025 annual figure was $25.7 million, up 21.12% from the prior year.
• Inventory was $30.5 million for Q1 2026 at Protalix BioTherapeutics, up from $25.7 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $30.5 million in Q1 2026 to a low of $14.6 million in Q3 2022.
• Historically, Inventory has averaged $20.3 million across 5 years, with a median of $20.3 million in 2023.
• The sharpest annual moves came in 2024 and 2026: Inventory retreated 20.31% in 2024, then surged 56.23% in 2026.
• A 5-year view of Inventory shows it stood at $16.8 million in 2022, then climbed by 13.34% to $19.0 million in 2023, then climbed by 11.54% to $21.2 million in 2024, then climbed by 21.12% to $25.7 million in 2025, then gained by 18.44% to $30.5 million in 2026.
• The last three Inventory figures came in at $30.5 million (Q1 2026), $25.7 million (Q4 2025), and $21.3 million (Q3 2025), per Business Quant data.